E-Learning

On Wednesday, ImmunityBio, Inc. (NASDAQ:IBRX) released progress in its ongoing FDA discussions regarding three areas of its clinical development pipeline in non-muscle invasive bladder cancer (NMIBC) and non-small cell lung cancer (NSCLC). NMIBC BCG Unresponsive Papillary Disease: ImmunityBio is preparing to submit a supplemental Biologics License Application (sBLA) in 2025 for its treatment targeting Bacillus Calmette-Guérin (BCG) unresponsive NMIBC in the papillary indication. As published in

(Bloomberg) -- A third straight year of outsize gains in US stocks — a display of strength last seen in the 1990s — leads Bank of America Corp.’s list of potential market surprises for 2025.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyNYC Commuters Get New Way to Dodge Traffic: $95 Helicopter RidesWill Americans Ever Lose Their Taste for Telework?Chicago Agency Pitches $1.5 Billion Plan to Fix Transit WoesChurches, Cinemas — and Moon Artifacts — Top List of E

Keefe, Bruyette & Woods analyst David Konrad reiterated an Outperform rating on the shares of Goldman Sachs Group Inc (NYSE:GS) and raised the price forecast to $690 from $686. The analyst notes Goldman Sachs posted an impressive quarterly performance, fueled by substantial gains in trading and continued growth in Asset Management. According to the analyst, trading revenue surged 33% year-over-year despite a tough comparison, with equities remaining stable quarter-over-quarter amid usual seasona

Despite the downturn in December, the Indian market is likely to have concluded 2024 with record-high sales.

While secondhand prices have fallen from their 2022 height, CPO programs, hype for vintage pieces and growing consumer interest contribute to continued strong growth.

Major U.S. indexes were little changed at midday Thursday after Wednesday's big gains powered by strong bank earnings and a softer-than-expected inflation report.

(Bloomberg) -- Quant giant AQR Capital Management has upgraded its expectations for the performance of a 60/40 portfolio in the years ahead, saying the classic investing approach is set to benefit from rising returns in the bond market.Most Read from BloombergThese Homes Withstood the LA Fires. Architects Explain WhyNYC Commuters Get New Way to Dodge Traffic: $95 Helicopter RidesChicago Agency Pitches $1.5 Billion Plan to Fix Transit WoesWill Americans Ever Lose Their Taste for Telework?Churches

In Brazil, Airwallex aims to tap B2B payment market with local accounts, card issuing, and payment acquiring services.

Lululemon claims improvement in a declining sector but its stock proves otherwise.

The brand's expansion plan includes 100 stores across India, Nepal, Sri Lanka and Bangladesh up to 2034.